Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
Sign Up to like & getrecommendations! Published in 2023 at "Renal Failure"
DOI: 10.1080/0886022x.2022.2164305
Abstract: Abstract Introduction It has been observed that intravenous iron administration may suppress endogenous production of erythropoietin (EPO). We postulate that this effect may be mediated by increased FGF-23 secretion. Aim of the study To evaluate… read more here.
Keywords: intravenous iron; iron; effect intravenous; fgf secretion ... See more keywords